GeneMachines has sold two OmniGrid microarrayers to the Genome Institute of Singapore, a new research institute that comprises part of the country’s promised $4 billion investment in genomics and biotechnology.

The Genome Institute will use the microarrayers in its genomics work on zebrafish and mouse model systems, cancer genomics, and other research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.